ArticleHealth science reports2025
Prevalence and Predictors of Cognitive Decline Among Diabetes Mellitus Patients Attending Jinja Regional Referral Hospital: A Cross-Sectional Study in Eastern Uganda.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The burden of cognitive impairment (CI) is high in diabetes mellitus. CI can adversely affect the self-care and management of diabetes, which results in an increase in the risk of hypo- or hyperglycaemic events and diabetic complications. The study aimed to determine the prevalence and predictors of CI in diabetic patients. Methods: A hospital-based, cross-sectional study was conducted among diabetic patients who were attending Jinja Regional Referral Hospital (JRRH), Eastern Uganda, from April to June 2024. A pre-designed data collection tool was used to capture socio-demographics and clinic profiles of the participants. A Montreal Cognitive Assessment (MoCA), version 8.1, was used to assess the CI (score: ≥ 26 = normal, < 26 = cognitive impairment) in diabetic patients. We used a binary and multiple logistic regression analysis to identify predictors of CI in diabetes. Results: The prevalence of CI among diabetic patients was 63.11% (95% CI: 58.3-67.9), and it was high among Type II diabetic patients (66.96%). Most of the patients have mild CI (73.77%). Delayed recall (78.96%) and language (73.77%) cognitive domains were greatly affected. Variables like advanced age (AOR = 6.08; 95% CI = 2.05-18.03), education (Illiterate: AOR = 5.90; 95% CI = 2.16-16.14; primary: AOR = 17.07; 95% CI = 5.64-51.71), alcohol use (AOR = 2.56; 95% CI = 1.22-5.37), no physical activity (AOR = 5.24; 95% CI = 2.52-10.91), type II diabetes (AOR = 7.02; 95% CI = 2.17-22.64), duration of diabetes (5-10 years: AOR = 14.09; 95% CI = 5.75-34.55; > 10 years: AOR = 78.80; 95% CI = 23.79-260.95), uncontrolled blood glucose (AOR = 5.13; 95% CI = 1.91-13.83), hypertension (AOR = 5.26; 95% CI = 2.08-13.34), and diabetic complications (AOR = 4.30; 95% CI = 1.38-13.36) were significantly associated with CI among diabetic patients. Conclusion: The study concludes that more than half of the diabetic patients had CI. Factors such as age, education, alcohol use, physical activity, diabetes type, duration of diabetes, glycaemic control, hypertension, and diabetic complications were significantly associated with CI in diabetes. Therefore, the study recommends planning and implementing management strategies that focus on predictors of CI in diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.